Rare diseases
Investigational molecules
Locations
Babraham Hall, Babraham Research Campus, CB22 3AT, United Kingdom
Artios Pharma Limited focuses on advanced or metastatic solid tumors, including advanced solid tumours and metastatic solid tumors, with clinical activity centered on patients whose disease has progressed beyond early-stage treatment options.
The sponsor’s clinical portfolio includes studies across multiple solid tumor settings, reflecting interest in difficult-to-treat oncology populations.
Artios Pharma Limited runs clinical trials in conditions such as Neoplasm malignant, Neoplasm, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Study of ART6043, Olaparib, and Niraparib in Patients with Advanced or Metastatic Solid Tumors
SpainStudy on the Safety and Effectiveness of ART0380 Alone or with Gemcitabine or Irinotecan for Patients with Advanced or Metastatic Solid Tumors
FranceStudy of ART0380 for Patients with Advanced or Metastatic Solid Tumors
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
